Hot Features
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Westlake Village BioPartners | Institution | 4 657 257 | 7,69% | US$ 37,03M | 2025-12-31 |
| Vida Ventures, LLC | Institution | 4 523 924 | 7,47% | US$ 35,97M | 2025-05-29 |
| Vida Ventures Advisors, LLC | Institution | 4 523 924 | 7,47% | US$ 35,97M | 2025-09-30 |
| GordonMD Global Investments LP | Institution | 4 244 818 | 7,01% | US$ 33,75M | 2026-03-31 |
| Gilead Sciences, Inc. | Institution | 4 126 119 | 6,82% | US$ 32,80M | 2026-03-31 |
| Westlake Biopartners Fund I, L.P. | Institution | 3 787 940 | 6,26% | US$ 30,11M | 2025-12-31 |
| Northpond Ventures, LLC | Institution | 3 466 826 | 5,73% | US$ 27,56M | 2025-12-31 |
| Bain Capital Life Sciences Investors, LLC | Institution | 3 110 000 | 5,14% | US$ 24,72M | 2026-03-31 |
| Northpond Ventures Iii, Lp | Institution | 2 805 426 | 4,63% | US$ 22,30M | 2025-12-31 |
| GordonMD Long Biased Master Fund LP | Institution | 2 735 783 | 4,52% | US$ 21,75M | 2025-11-13 |
| Deerfield Management Company, L.P. | Institution | 2 000 000 | 3,30% | US$ 15,90M | 2026-03-31 |
| Aigh Capital Management, LLC | Institution | 2 000 000 | 3,30% | US$ 15,90M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1 783 342 | 2,95% | US$ 14,18M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 1 555 287 | 2,57% | US$ 12,36M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 1 125 321 | 1,86% | US$ 8,95M | 2026-03-31 |
| Millennium Management LLC | Institution | 1 005 508 | 1,66% | US$ 7,99M | 2026-03-31 |
| Insight Venture Management, LLC | Institution | 989 054 | 1,63% | US$ 7,86M | 2026-03-31 |
| Morgan Stanley | Institution | 947 927 | 1,57% | US$ 7,54M | 2026-03-31 |
| BlackRock, Inc. | Institution | 877 078 | 1,45% | US$ 6,97M | 2026-03-31 |
| Westlake BioPartners Opportunity Fund I, L.P. | Institution | 869 317 | 1,44% | US$ 6,91M | 2025-12-31 |
| Woodline Partners LP | Institution | 845 325 | 1,40% | US$ 6,72M | 2026-03-31 |
| Medical Strategy GmbH | Institution | 746 530 | 1,23% | US$ 5,93M | 2025-12-31 |
| D. E. Shaw & Co., L.P. | Institution | 721 581 | 1,19% | US$ 5,74M | 2026-03-31 |
| MBB Public Markets I LLC | Institution | 614 477 | 1,02% | US$ 4,89M | 2026-03-31 |
| Marshall Wace LLP | Institution | 605 512 | 1,00% | US$ 4,81M | 2026-03-31 |
| Susquehanna International Group, LLP | Institution | 605 446 | 1,00% | US$ 4,81M | 2026-03-31 |
| Adage Capital Management, L.P. | Institution | 500 000 | 0,83% | US$ 3,98M | 2026-03-31 |
| Propel Bio Management, LLC | Institution | 471 315 | 0,78% | US$ 3,75M | 2026-03-31 |
| Northpond Ventures LP | Institution | 450 000 | 0,74% | US$ 3,58M | 2025-12-31 |
| UBS Asset Management AG | Institution | 449 750 | 0,74% | US$ 3,58M | 2026-03-31 |
| Dr. Dominic Borie | Initiés | 449 210 | 0,74% | US$ 3,57M | 2025-03-15 |
| Geode Capital Management, LLC | Institution | 423 826 | 0,70% | US$ 3,37M | 2026-03-31 |
| BNP Paribas Financial Markets SNC | Institution | 412 032 | 0,68% | US$ 3,28M | 2026-03-31 |
| Dr. Peter Maag | Initiés | 407 541 | 0,67% | US$ 3,24M | 2025-03-15 |
| Renaissance Technologies LLC | Institution | 367 492 | 0,61% | US$ 2,92M | 2026-03-31 |
| Qube Research & Technologies Ltd | Institution | 333 692 | 0,55% | US$ 2,65M | 2026-03-31 |
| Vida Ventures III, L.P. | Institution | 253 719 | 0,42% | US$ 2,02M | 2025-05-29 |
| Vanguard Fiduciary Trust Company | Institution | 224 584 | 0,37% | US$ 1,79M | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 222 929 | 0,37% | US$ 1,77M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 211 088 | 0,35% | US$ 1,68M | 2026-03-31 |
| Burkehill Global Management, LP | Institution | 200 000 | 0,33% | US$ 1,59M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 192 019 | 0,32% | US$ 1,53M | 2026-03-31 |
| Invesco Capital Management LLC | Institution | 186 674 | 0,31% | US$ 1,48M | 2026-03-31 |
| Two Sigma Investments, LP | Institution | 181 615 | 0,30% | US$ 1,44M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.